Multicenter Study of Lumateperone for the Treatment of Irritability Associated With Autism Spectrum Disorder (ASD) in Pediatric Patients

Recruiting

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(39 sites)

United States

Clinical Site, Little Rock, Arkansas

Clinical Site, Imperial, California

Clinical Site, Sacramento, California

Clinical Site, Sherman Oaks, California

Clinical Site, New Haven, Connecticut

Clinical Site, Hialeah, Florida

Clinical Site, Miami, Florida

Clinical Site, Miami Gardens, Florida

Clinical Site, Miami Lakes, Florida

Clinical Site, Orlando, Florida

Clinical Site, Pompano Beach, Florida

Clinical Site, Atlanta, Georgia

Clinical Site, Lawrenceville, Georgia

Clinical Site, Naperville, Illinois

Clinical Site, Evansville, Indiana

Clinical Site, Indianapolis, Indiana

Clinical Site, Boston, Massachusetts

Clinical Site, Bloomfield Hills, Michigan

Clinical Site, St Louis, Missouri

Clinical Site, Lincoln, Nebraska

Clinical Site, Orangeburg, New York

Clinical Site, Staten Island, New York

Clinical Site, The Bronx, New York

Clinical Site, Kinston, North Carolina

Clinical Site, Avon Lake, Ohio

Clinical Site, Oklahoma City, Oklahoma

Clinical Site, Charleston, South Carolina

Clinical Site, Austin, Texas

Clinical Site, Coppell, Texas

Clinical Site, Dallas, Texas

Clinical Site, Fort Worth, Texas

Clinical Site, Houston, Texas

Clinical Site, Richmond, Virginia

Clinical Site, Everett, Washington